Novo Nordisk's pricing tactics inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of selling price gouging, stating the stark contrast among U.S. selling prices and those in Europe and copyright.This led Novo Nordisk to perform additional analysis into bigger dosages of semaglutide especiall